{"id":282411,"date":"2026-10-01T09:51:32","date_gmt":"2026-10-01T04:21:32","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=282411"},"modified":"2026-10-01T09:51:32","modified_gmt":"2026-10-01T04:21:32","slug":"lincoln-best-stock-in-its-sector","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/lincoln-best-stock-in-its-sector\/","title":{"rendered":"Is Lincoln Pharmaceuticals the Best Stock in Its Sector? A Look at the Numbers"},"content":{"rendered":"

Lincoln Pharmaceuticals CMP Rs 586 (01 Oct 2026). Market cap Rs 1,172 Cr. ROE 11.60%. P\/E 12.15x versus Industry P\/E 38.34x.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Lincoln Pharmaceuticals is one of the names investors compare when screening the Healthcare sector, built on a 11.60% return on equity and a P\/E of 12.15x against an Industry P\/E of 38.34x. Whether Lincoln Pharmaceuticals is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named Healthcare sector peers, so you can judge that for yourself.<\/p>\n<\/p><\/div>\n

Is Lincoln Pharmaceuticals<\/a> the best stock in its sector? The stock trades on the NSE at Rs 586 as of 01 October 2026, within its 52-week range of Rs 440.00 to Rs 770.00. Lincoln Pharmaceuticals Ltd manufactures pharmaceutical formulations, with a significant export presence in emerging markets.<\/p>\n

Lincoln Pharmaceuticals sits in the Healthcare sector, and its 11.60% ROE and 12.15x P\/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector’s Industry P\/E benchmark.<\/p>\n

Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers<\/a><\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n